TY  - GEN 
AU  - Salvador-Martín, Sara
AU  - Raposo-Gutiérrez, Irene
AU  - Navas-López, Víctor Manuel
AU  - Gallego-Fernández, Carmen
AU  - Moreno Alvarez, Ana
AU  - Solar Boga, Alfonso
AU  - Muñoz-Codoceo, Rosana
AU  - Magallares, Lorena
AU  - Martínez-Ojinaga, Eva
AU  - Fobelo, María J
AU  - Millán-Jiménez, Antonio
AU  - Rodriguez-Martinez, Alejandro
AU  - Vayo, Concepción A
AU  - Sánchez, Cesar
AU  - Tolin, Mar
AU  - Bossacoma, Ferrán
AU  - Pujol-Muncunill, Gemma
AU  - González de Caldas, Rafael
AU  - Loverdos, Inés
AU  - Blanca-García, José A
AU  - Segarra, Oscar
AU  - Eizaguirre, Francisco J
AU  - García-Romero, Ruth
AU  - Merino-Bohórquez, Vicente
AU  - Sanjurjo-Sáez, María
AU  - López-Fernández, Luis A
PY  - 2020
SN  - 1661-6596
UR  - http://hdl.handle.net/20.500.11940/16288
AB  - Around a 20-30% of inflammatory bowel disease (IBD) patients are diagnosed before they are 18 years old. Anti-TNF drugs can induce and maintain remission in IBD, however, up to 30% of patients do not respond. The aim of the work was to identify...
KW  - Inflammatory Bowel Diseases
KW  - Toll-Like Receptor 2
KW  - Adolescent
KW  - RNA
KW  - alpha-Defensins
KW  - Anti-Inflammatory Agents
KW  - Transcriptome
KW  - Tumor Necrosis Factor-alpha
KW  - Humans
KW  - Antirheumatic Agents
KW  - Treatment Outcome
KW  - Smad7 Protein
KW  - Gene Expression Regulation
KW  - Infant
TI  - Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease
DO  - 10.3390/ijms21093364
KW  - CHUAC
VL  - 21
ER  -